Neuphoria Therapeutics NEUP
NASDAQ NEUP
$2.71 +0.02 (+0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Neuphoria Therapeutics (NEUP) Asset Utilization Ratio (2025)

Updated

Neuphoria Therapeutics' Asset Utilization Ratio came in at 0.04 for FY2026 (year ended Jun 30, 2026), down 92.6% from 0.56 in FY2025.

Analysis

Neuphoria Therapeutics (NEUP) Asset Utilization Ratio (2025) Analysis & Trends

Going back to FY2022, Neuphoria Therapeutics' Asset Utilization Ratio data covers 4 fiscal years.

  • The FY2026 figure represents the lowest annual Asset Utilization Ratio since FY2023.
  • Per Business Quant, earlier fiscal years put Asset Utilization Ratio at 0.56 in FY2025, 0.00 in FY2023 (-90.8%) and 0.00 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 0.60
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 0.47
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 0.51
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 0.50
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 0.41
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 0.62
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.31
10 Neuphoria Therapeutics 335.34 Mn 260.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 0.53
API Access

Neuphoria Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=NEUP&period=max&api_key=YOUR_API_KEY